Patent details

EP3500575 Title: CRYSTALLINE FORM OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE, PREPARATION, AND USES THEREOF

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
04/12/2025
Unitary Effect Status:
Unitary Effect Registered
Request Unitary Effect Accepted:
09/01/2026
Unitary Effect Date:
05/11/2025
Unitary Effect Registration Date:
09/01/2026
Request Unitary Effect Rejected:
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Unitary Effect Request Withdrawal Date:
Unitary Effect request has been accepted, please see the UPP register at the EPO for up-to-date information
UPP register:
EP3500575
SPC Number:
Creation Date:

Basic Information

Publication number:
EP3500575
WO Application Number:
IB2017054955
Type:
European Patent Granted for NL
Status:
Unitary Effect Registered
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP17841172.4
WO Publication Number:
WO2018033853
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
15/08/2017
Grant date:
05/11/2025
EP Publication Date:
26/06/2019
WO Publication Date:
22/02/2018
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
05/11/2025
EP B1 Publication Date:
05/11/2025
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
14/08/2037
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
05/11/2025
 
 

 

Name:
BeiGene Switzerland GmbH
Address:
Aeschengraben 27, 4051 Basel, Switzerland (CH)

Inventor

1

Name:
WANG, Zhiwei
Address:
Beijing 102206, China (CN)

2

Name:
GUO, Yunhang
Address:
Beijing 102206, China (CN)

3

Name:
SHI, Gongyin
Address:
Beijing 102206, China (CN)

Priority

Priority Patent Number:
PCT/CN2016/095510
Priority Date:
16/08/2016
Priority Country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC or IDT classification:
C07D 487/04; A61K 31/519; A61P 37/00; A61P 29/00; A61P 35/00;

Publication

Bulletin

1

Bulletin Heading:
UP1
Journal edition number:
06/26
Publication date:
11/02/2026
Description:
European patents with registered Unitary Effect

2

Bulletin Heading:
EP2
Journal edition number:
45/25
Publication date:
05/11/2025
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202609
Publication date:
25/02/2026
Description:
Document reprinted after correction (B8, B9)

2

Issue number:
202607
Publication date:
11/02/2026
Description:
Unitary Effect Request Acceptance

3

Issue number:
202602
Publication date:
07/01/2026
Description:
Unitary Effect Request Receipt

4

Issue number:
202545
Publication date:
05/11/2025
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type